High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab. Watanabe S, Suzukawa M, Tashimo H, Ohshima N, et al. J Asthma 2021 Jun 13:1-11. doi: 10.1080/02770903.2021.1942039.

Read + Share

Amedeo Smart

Independent Medical Education

Watanabe S, Suzukawa M, Tashimo H, Ohshima N, et al. High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab. J Asthma 2021 Jun 13:1-11. doi: 10.1080/02770903.2021.1942039.
PMID: 34121592